Jenell Volkov News Today : Breaking News, Live Updates & Top Stories | Vimarsana

PHILADELPHIA, May 02, 2023 Cabaletta Bio, Inc. , a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with. | May 2, 2023

United statesJinmin leeSarah mccabeJason pengLos angelesAnup mardaSamik basuDaniel nunezJenell volkovLos angeles convention centerCabaletta bio incPreclinical researchAmerican society of geneStern investor relations incExchange commissionChief scientific officer